KLRS (STOCKS)
Kalaris Therapeutics, Inc. Common Stock
$4.720000
+0.170000 (+3.74%)
Prev close: $4.550000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Andrew Oxtoby
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $111.59M
- Employees
- 20
- P/E (TTM)
- -2.21
- P/B (TTM)
- 1.58
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.46 | $-0.53 | +0.0736 | +13.79% |
|
Dec 2025 (Q4)
|
$-0.51 | $-0.54 | +0.0321 | +5.92% |
|
Sep 2025 (Q3)
|
$-0.64 | $-0.67 | +0.0259 | +3.89% |
|
Jun 2025 (Q2)
|
$-0.61 | $-0.53 | -0.0796 | -15.01% |